Delphi has been legal advisor to AddLife AB when listing on Nasdaq Stockholm.
AddLife AB is a leading independent Nordic player within Life Science with an estimated annual sale of approximately SEK 1.7 billion. AddLife has 25 subsidiaries and 450 employees in the Nordic countries. Clients are operating in the healthcare, laboratories and research in the private and public sectors. AddLife provides high-quality technology products, services and qualified advice in all Nordic markets.
Through the IPO AddLife expects an increased exposure to attract more talents and more acquisition candidates as a defined Life Science company.
Handelsbanken has acted as financial advisor to AddLife.
Delphi’s transaction team consisted of responsible partner Mats Dahlberg, primarily assisted by Andreas Wirén and Marcus Halling. Emma Dansbo and Frida Lager have been responsible for DD. In addition, a large number of lawyers from the Stockholm office have been involved in the transaction.
Your consent means that we collect information about your device and how you use the website which is linked to what Google knows. You can withdraw your consent by, for example, clicking on “Manage cookies” in the footer at the bottom of the page or contacting us at privacy@delphi.se.
We also use necessary cookies that enable core functionality. We do not require your consent to use these cookies. You can read a detailed description on how we use cookies, how you can avoid our cookies and also how to withdraw your consent here. Our use of cookies also entails processing of your personal data. Advokatfirman Delphi Stockholm AB is the data controller and responsible for the processing, which you can read more about here. You will also find information about your rights in relation to our processing of your personal data, namely the right to withdraw your consent, the right to object to our processing, the right of access, the right to rectification, the right to erasure and restriction, the right to data portability and the right to lodge a complaint.